• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性脑卒中患者的偶发性脑动脉瘤:与无症状健康对照者的比较。

Incidental cerebral aneurysms in acute stroke patients: comparison of asymptomatic healthy controls.

机构信息

Department of Neurology, Toho University Omori Medical Center, 6-11-1, Omorinishi, Otaku, Tokyo, 143-8541, Japan.

出版信息

J Neurol Sci. 2010 Nov 15;298(1-2):42-5. doi: 10.1016/j.jns.2010.08.069.

DOI:10.1016/j.jns.2010.08.069
PMID:20864121
Abstract

Cerebral aneurysms (CA) are incidentally detected by magnetic resonance angiography (MRA) in acute stroke patients or asymptomatic volunteers. We investigated whether incidental CA influences stroke subtypes and clinical outcome of patients with acute brain infarction (BI) and hemorrhage (BH). Moreover, frequency and neuroradiological profile of incidental CA were compared between acute stroke patients and asymptomatic healthy controls. We included consecutive BI and BH patients who underwent magnetic resonance imaging and MRA within 7 days from clinical onset. CA diagnosis was performed by 3-dimensional time-of-flight MRA. Demographics, risk factors, stroke subtypes, and modified Rankin scale (mRS) at 3 months after stroke were assessed. Incidental CA was detected in 18 (3.7%) of 481 stroke patients, 13 (3.5%) of 374 BI patients, 5 (4.7%) of 107 BH patients, and 146 (2.0%) of 7345 controls. Multivariate analysis showed no significant differences in CA frequency between BI, BH, and control groups. Female sex was associated independently with incidental CA in the stroke (P<0.01), BI (P<0.05), BH (P<0.05), and healthy control groups (P<0.01). No statistical differences in CA size and location between the 4 groups were found. BI subtypes and BH sites were not correlated with incidental CA. CA rupture or subarachnoid hemorrhage did not occur until 3 months after stroke. The 3-month mRS score did not differ between stroke patients with and without CA. Prevalence of incidental CA did not differ statistically among stroke, BI, BH patients and healthy asymptomatic subjects. The 3-month mRS score was not affected by incidental CA. Female sex was only an independent factor for incidental CA. Thus, we should pay more attention to incidental CA in female BI patients treated with tissue plasminogen activator.

摘要

颅内动脉瘤(CA)在急性脑卒中患者或无症状志愿者中通过磁共振血管造影(MRA)偶然发现。我们研究了偶然发现的 CA 是否影响急性脑梗死(BI)和脑出血(BH)患者的脑卒中亚型和临床结局。此外,还比较了急性脑卒中患者和无症状健康对照者偶然 CA 的频率和神经影像学特征。我们纳入了发病后 7 天内接受磁共振成像和 MRA 的连续 BI 和 BH 患者。通过三维时间飞越 MRA 进行 CA 诊断。评估了人口统计学、危险因素、脑卒中亚型和脑卒中后 3 个月的改良 Rankin 量表(mRS)评分。在 481 例脑卒中患者中发现 18 例(3.7%),374 例 BI 患者中发现 13 例(3.5%),107 例 BH 患者中发现 5 例(4.7%),7345 例对照组中发现 146 例(2.0%)。多变量分析显示,BI、BH 和对照组之间 CA 的频率无显著差异。女性与脑卒中(P<0.01)、BI(P<0.05)、BH(P<0.05)和健康对照组(P<0.01)中的偶然 CA 独立相关。4 组之间 CA 大小和位置无统计学差异。BI 亚型和 BH 部位与偶然 CA 无关。CA 破裂或蛛网膜下腔出血直到脑卒中后 3 个月才发生。有和无 CA 的脑卒中患者 3 个月 mRS 评分无差异。脑卒中、BI、BH 患者和健康无症状者偶然 CA 的发生率无统计学差异。偶然 CA 不影响 3 个月 mRS 评分。女性是偶然 CA 的唯一独立因素。因此,我们应该更加关注接受组织型纤溶酶原激活剂治疗的 BI 女性患者中的偶然 CA。

相似文献

1
Incidental cerebral aneurysms in acute stroke patients: comparison of asymptomatic healthy controls.急性脑卒中患者的偶发性脑动脉瘤:与无症状健康对照者的比较。
J Neurol Sci. 2010 Nov 15;298(1-2):42-5. doi: 10.1016/j.jns.2010.08.069.
2
Safety of intravenous thrombolysis in acute ischemic stroke patients with saccular intracranial aneurysms.颅内囊状动脉瘤急性缺血性脑卒中患者静脉溶栓的安全性。
J Stroke Cerebrovasc Dis. 2013 Jul;22(5):639-43. doi: 10.1016/j.jstrokecerebrovasdis.2012.01.009. Epub 2012 Feb 15.
3
Clinicoradiologic features of vertebrobasilar dolichoectasia in stroke patients.椎基底动脉延长扩张症患者的临床影像学特征。
J Stroke Cerebrovasc Dis. 2012 Jan;21(1):5-10. doi: 10.1016/j.jstrokecerebrovasdis.2010.04.003. Epub 2010 Sep 15.
4
Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.49例接受静脉注射组织纤溶酶原激活剂治疗的中风患者中,预处理MRI参数对临床结局、再通及梗死灶大小的影响
J Neurol Sci. 2004 Oct 15;225(1-2):3-9. doi: 10.1016/j.jns.2004.05.020.
5
Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusion<or=3 h and 3-6 h.基于磁共振成像的溶栓治疗对大脑中动脉闭塞≤3小时和3 - 6小时患者的比较
Neurol India. 2009 Jul-Aug;57(4):426-33. doi: 10.4103/0028-3886.55615.
6
Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.在急性缺血性中风患者中,t-PA治疗后1至24小时内再通是脑出血的有力预测指标。
J Neurol Sci. 2008 Jul 15;270(1-2):48-52. doi: 10.1016/j.jns.2008.01.013. Epub 2008 Mar 4.
7
Long-term follow-up of incidental intracranial aneurysms in patients with acute ischemic stroke.急性缺血性脑卒中患者偶然发现颅内动脉瘤的长期随访。
J Stroke Cerebrovasc Dis. 2013 May;22(4):329-33. doi: 10.1016/j.jstrokecerebrovasdis.2011.09.011. Epub 2011 Oct 20.
8
Incidental unruptured intracranial aneurysms in patients with acute ischemic stroke.急性缺血性卒中患者的偶然未破裂颅内动脉瘤
Cerebrovasc Dis. 2008;26(6):650-3. doi: 10.1159/000166842. Epub 2008 Nov 4.
9
Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery.经MRI检测,t-PA溶栓后缺血性脑组织的出血性转化可能无症状,但会损害神经功能恢复。
J Neurol Sci. 2008 Sep 15;272(1-2):136-42. doi: 10.1016/j.jns.2008.05.012. Epub 2008 Jul 7.
10
Arterial occlusion sites on magnetic resonance angiography influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischaemic stroke.磁共振血管造影显示的动脉闭塞部位影响缺血性脑卒中患者静脉注射小剂量(0.6mg/kg)阿替普酶治疗的疗效。
Int J Stroke. 2009 Dec;4(6):425-31. doi: 10.1111/j.1747-4949.2009.00347.x.

引用本文的文献

1
The risk of endovascular thrombectomy in acute ischemic stroke patients with large vessel occlusions harboring unruptured intracranial aneurysms.伴有未破裂颅内动脉瘤的大血管闭塞急性缺血性卒中患者进行血管内血栓切除术的风险。
BMC Neurol. 2025 Jul 1;25(1):269. doi: 10.1186/s12883-025-04283-5.
2
Prevalence and prognosis of acute ischemic stroke coexisting with unruptured intracranial aneurysms.急性缺血性卒中合并未破裂颅内动脉瘤的患病率及预后
Front Neurol. 2023 Nov 30;14:1286193. doi: 10.3389/fneur.2023.1286193. eCollection 2023.
3
Mechanical Thrombectomy for Acute Cerebral Large Vessel Occlusions Involving a Cerebral Aneurysm in the Target Vessel.
针对累及目标血管内脑动脉瘤的急性脑大血管闭塞进行机械取栓术。
J Neuroendovasc Ther. 2021;15(1):8-13. doi: 10.5797/jnet.oa.2020-0103. Epub 2020 Sep 1.
4
Prevalence and risk factors of unruptured intracranial aneurysms in ischemic stroke patients - A global meta-analysis.缺血性脑卒中患者未破裂颅内动脉瘤的患病率及危险因素——一项全球荟萃分析。
Surg Neurol Int. 2023 Jun 30;14:222. doi: 10.25259/SNI_190_2023. eCollection 2023.
5
Characteristics and Outcomes of Thrombolysis-Treated Stroke Patients With and Without Saccular Intracranial Aneurysms.溶栓治疗的伴有和不伴有囊状颅内动脉瘤的卒患者的特征和结局。
Stroke. 2022 Dec;53(12):3616-3621. doi: 10.1161/STROKEAHA.122.040151. Epub 2022 Oct 18.
6
Prevalence of unruptured intracranial aneurysms among first-degree relatives of Thai patients who had aneurysmal subarachnoid hemorrhage.泰国动脉瘤性蛛网膜下腔出血患者一级亲属中未破裂颅内动脉瘤的患病率。
Surg Neurol Int. 2021 Nov 23;12:566. doi: 10.25259/SNI_741_2021. eCollection 2021.
7
Incidental Unruptured Intracranial Aneurysms Do Not Impact Outcome in Patients With Acute Cerebral Infarction.偶然发现的未破裂颅内动脉瘤不影响急性脑梗死患者的预后。
Front Neurol. 2021 Apr 26;12:613027. doi: 10.3389/fneur.2021.613027. eCollection 2021.
8
Prevalence of intracranial aneurysms among acute ischemic stroke patients.急性缺血性脑卒中患者颅内动脉瘤的患病率。
Surg Neurol Int. 2020 Oct 15;11:341. doi: 10.25259/SNI_506_2020. eCollection 2020.
9
Prevalence, predictors and prognosis of incidental intracranial aneurysms in patients with suspected TIA and minor stroke: a population-based study and systematic review.疑似 TIA 和小卒中患者中偶然发现的颅内动脉瘤的患病率、预测因素和预后:一项基于人群的研究和系统评价。
J Neurol Neurosurg Psychiatry. 2021 May;92(5):542-548. doi: 10.1136/jnnp-2020-324418. Epub 2020 Nov 4.
10
Prevalence of Intracranial Aneurysm in Women With Fibromuscular Dysplasia: A Report From the US Registry for Fibromuscular Dysplasia.纤维肌发育不良女性颅内动脉瘤的患病率:来自美国纤维肌发育不良登记处的报告。
JAMA Neurol. 2017 Sep 1;74(9):1081-1087. doi: 10.1001/jamaneurol.2017.1333.